Skip to main content

Table 1 Demographic and clinical features of groups

From: The effects of Desflurane and Sevoflurane on Nesfatin-1 levels in laparoscopic Cholecystectomy: a randomized controlled trial

Parameters

Desflurane (n = 21)

Sevoflurane (n = 21)

p-value

Age (years)

49.6 ± 9.3

49.8 ± 10.9

0.943a

Sex

  

0.306b

 Male

4 (19.0%)

8 (38.1%)

 

 Female

17 (81.0%)

13 (61.9%)

 

ASA

  

1.000b

 I

11 (52.4%)

10 (47.6%)

 

 II

10 (47.6%)

11 (52.4%)

 

Height (m)

1.64 ± 0.10

1.66 ± 0.10

0.566a

Body weight (kg)

84.0 ± 17.9

79.3 ± 13.2

0.366a

Body-mass index (kg/m2)

31.2 ± 5.9

28.9 ± 5.2

0.210a

Comorbid diseases

10 (47.6%)

11 (52.4%)

1.000b

 DM

1 (4.8%)

6 (28.6%)

0.093c

 HT

7 (33.3%)

6 (28.6%)

1.000b

 Asthma

2 (9.5%)

4 (19.0%)

0.663c

 Others

4 (19.0%)

3 (14.3%)

1.000c

  1. a Student’s t test, b Continuity corrected chi-square test, cFisher’s exact test. Others: thyroid, hematological, neurological and rheumatological diseases